购物车
- 全部删除
- 您的购物车当前为空
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 1,992 | 期货 | |
10 mg | ¥ 3,369 | 期货 |
产品描述 | FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |
密度 | no data available |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | H2O: 50 mg/mL (48.59 mM), Sonication is recommended. |
评论内容